Javier Lopez-Jiménez

13PUBLICATIONS
126CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyPredictive and prognostic markersInnate immunityCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 27, 2026
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-Bulky Hodgkin Lymphoma, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles: The RAFTING Trial Protocol.

|Jan 28, 2026
Apheresis CD8+CCR7+CD45RA- T-Cells as a Novel Biomarker Associated with CAR T-Cell Kinetics and Clinical Outcome.

Iván García de la Torre, Carlota García-Hoz, Fernando Martin-Moro

|Jan 08, 2025
The Value of Bone Marrow Assessment by FDG PET/CT, Biopsy and Aspirate in the Upfront Evaluation of Mantle Cell Lymphoma: A Nationwide Cohort Study.

Isabel Ródenas Quiñonero, Javier Marco-Ayala, Tzu-Hua Chen-Liang

|Jul 22, 2024
Curative Strategy for High-Risk Smoldering Myeloma: Carfilzomib, Lenalidomide, and Dexamethasone (KRd) Followed by Transplant, KRd Consolidation, and Rd Maintenance.

María-Victoria Mateos, Joaquin Martínez-López, Paula Rodriguez Otero

|Apr 29, 2024
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression.

A Medina-Herrera, I Vazquez, I Cuenca

|Mar 27, 2024
A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis.

Jesús Fortún, Elia Gómez-García de la Pedrosa, Alberto Martínez-Lorca

Pageof 3

Frequent Collaborators

4 joint publications

Joaquin Martínez-López

3 joint publications

Ramón García-Sanz

3 joint publications

Adrián Alegre

3 joint publications

Jose-Ángel Hernández-Rivas